Are these tests a very wise choice?
A decade ago, companies started developing saliva-based, at-home hereditary tests that provide individuals the capability to find out more about their traits that are genetic. These tests began with ancestry information, then evolved to incorporate faculties (such as for example hair loss and locks color), predispositions for health problems (such as for example Parkinson’s condition and cancer of the breast), and reactions to certain prescription drugs. These “direct-to-consumer” (DTC) tests provide fast, cheap hereditary assessment without the need to consult well a physician… But is it a choice that is wise? And exactly how if the outcomes be interpreted and used?
Understand the restrictions: mail-order tests are neither comprehensive nor definitive
In March 2018, the usa Food and Drug management authorized DTC business 23andMe to report on dangers pertaining to the BRCA2 and BRCA1 genes. These genes had been catapulted to popularity in 2013 by Angelina Jolie, whom opened about her experience and preventative alternatives as a provider of a BRCA1 mutation.